Ethyl 5-amino-1-(2-fluorobenzyl)-1H-pyrazole-3-carboxylate, 98+%, 100g

2-Difluoromethoxy-5-methyl-phenylamine, 25g

5-(1H-Imidazol-1-yl)-2-pyridinamine, 95%, 1g

3,4-Dichlorobenzoylacetonitrile, 96.0%, 1g

tert-Butyl ((3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl)carbamate, 98%, 100mg

trans,trans-4'-Butyl-4-(3,4-difluorophenyl)bicyclohexyl>98.0%(GC)25g

4-(1,3,4-Oxadiazol-2-yl)pyridine, 95+%, 5g

4,4'-((Perfluoro-[1,1'-biphenyl]-4,4'-diyl)bis(oxy))dibenzonitrile, 98%, 100mg

acteoside, with analyt. Documents, 20 mg, glass packaging

2-Bromo-4-nitroanisole>98.0%(GC)5g

2-Methyl-benzothiazole-5-carboxylic acid, 95.0%, 1g

250 ml round bottle HDPE natural RD 22 cylindrical

2-(2-Bromoethyl)-2H-1,2,3-triazole, 95.0%, 100mg